Welcome to LookChem.com Sign In|Join Free
  • or
(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl chloride, also known as feruloyl chloride, is an organic chloride compound with the chemical formula C12H13ClO4. It is derived from ferulic acid, a phenolic compound found in various plants. This enoyl chloride is known for its reactivity and is widely used in organic synthesis for the preparation of synthetic intermediates. Its versatile chemical properties also make it a valuable component in the production of pharmaceuticals and agrochemicals.

10263-19-1

Post Buying Request

10263-19-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10263-19-1 Usage

Uses

Used in Organic Synthesis:
(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl chloride is used as a reagent in organic synthesis for the preparation of various synthetic intermediates. Its reactivity allows for the formation of new chemical bonds and the creation of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, (2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl chloride is used as a key intermediate in the synthesis of various drugs. Its ability to form stable bonds with other molecules makes it a valuable component in the development of new pharmaceutical compounds.
Used in Agrochemical Production:
(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl chloride is also utilized in the agrochemical industry for the production of pesticides and other agricultural chemicals. Its reactivity and stability contribute to the effectiveness and longevity of these products.

Check Digit Verification of cas no

The CAS Registry Mumber 10263-19-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,6 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 10263-19:
(7*1)+(6*0)+(5*2)+(4*6)+(3*3)+(2*1)+(1*9)=61
61 % 10 = 1
So 10263-19-1 is a valid CAS Registry Number.

10263-19-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl chloride

1.2 Other means of identification

Product number -
Other names (E)-3-(3,4,5-trimethoxyphenyl)acryloyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10263-19-1 SDS

10263-19-1Relevant academic research and scientific papers

Radiosensitization of human pancreatic cancer by piperlongumine analogues

Ma, Hao,Wu, Yuelin,Zhang, Wannian,Zhang, Huojun,Miao, Zhenyuan,Zhuang, Chunlin

, p. 1197 - 1201 (2021)

Radiotherapy is commonly used to treat advanced pancreatic cancers and can improve survival by 2 months in combination with gemcitabine. However, prognosis and survival improvement remain unsatisfactory, and effective therapies are urgently needed. Piperlongumine has been demonstrated to have therapeutic potentials against various cancers. In this study, we synthesized a series of piperlongumine derivatives and provided evidence that piperlongumine derivatives could be used as effective radiosensitizers in pancreatic cancer. Two compounds enhanced the radiosensitivity of Panc-1 and SW1990 cells. In a pancreatic bi-flank xenograft tumor model, they significantly inhibited tumor growth. Piperlongumine derivatives could induce reactive oxygen species (ROS) expression and regulate the Keap1-Nrf2 protective pathway with enhancement of radiation-induced DNA damage, G2/M-phase cell cycle arrest, and apoptosis. Collectively, our data offer a proof of concept for the use of piperlongumine derivatives as a novel class of radiosensitizers for the treatment of pancreatic cancer.

Mild, Metal-Free and Protection-Free Transamidation of N-Acyl-2-piperidones to Amino Acids, Amino Alcohols and Aliphatic Amines and Esterification of N-Acyl-2-piperidones

Subramani, Muthuraman,Rajendran, Saravana Kumar

, p. 3677 - 3686 (2019)

Amides are indispensable building blocks of biological systems, pharmaceuticals, and materials. We report a highly selective method for the synthesis of amides via transamidation process. Transamidation of N-acyl-2-piperidones with a broad range of amines is demonstrated under exceedingly mild and metal-free reaction condition that relies on the amide bond twist to weaken the amidic resonance. Transamidation proceeds under the neat condition at room temperature, in short reaction times (30–90 min) with good yields. Considerable variation is tolerated with both amine and imide substrates. Of note, amines bearing carboxylic acids (glycine and serine) and hydroxyl groups (dopamine, tyramine, etc.) are well tolerated which are otherwise problematic under the metal-catalyzed protocol. Our current method is applicable for transamidation of both alkyl and aryl-N-acyl-2-piperidones. The practical value of the method is highlighted by the synthesis of four natural product amide alkaloids in high yields under mild reaction conditions. In the absence of nucleophilic amines, N-acyl-2-piperidones undergoes esterification with EtOH at elevated temperature. Single crystal X-ray analysis of an N-acyl-2-piperidone shows amide bond twist, τ = –20.39° and pyramidalization, χN = –11.73°. This weakens the amidic conjugation and might be the factor controlling the reactivity and selectivity of these imides. We envision that the N-acyl-2-piperidone scaffold would be useful in the synthesis of pharmaceuticals and materials.

Synthesis and biological evaluation of N-cinnamoyl and mandelate metformin analogues

Anitha Kumari,Bharathi,Prabhu,Ponnudurai

, p. 1895 - 1898 (2016)

A series of N,N-dimethyl-N1-[3-(substituted phenyl)-1-oxo-2-propenyl]biguanides were synthesized by coupling a solution of metformin in pyridine with different cinnamoyl chloride derivatives in ether for 3 h in addition to synthesis of some five molecules of metformin-mandelates. All the synthesized cinnamoyl metformins and a few metformin-mandelates were characterized by IR, NMR and Mass spectroscopic techniques. All the synthesized compounds were also evaluated for their antioxidant activity by DPPH scavenging method and nitric oxide scavenging method. All the compounds exhibited good antioxidant activity.

Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis

Chen, Liu Zeng,Shu, Hai Yang,Wu, Jing,Yu, Yun Long,Ma, Duo,Huang, Xin,Liu, Ming Ming,Liu, Xin Hua,Shi, Jing Bo

, (2021)

In order to discover and develop drug-like anti-inflammatory agents against arthritis, based on “Hit” we found earlier and to overcome drawbacks of toxicity, twelve series of total 89 novel pyrimidine, pyrazolo[4,3-d]pyrimidine and thieno[3,2-d]pyrimidine derivatives were designed, synthesized and screened for their anti-inflammatory activity against NO and toxicity for normal liver cells (LO2). Relationships of balance toxicity and activity have been summarized through multi-steps, and title compounds 22o, 22l were found to show lower toxicity (against LO2: IC50 = 2934, 2301 μM, respectively) and potent effect against NO release (IR = 98.3, 97.67%, at 10 μM, respectively). Furthermore, compound 22o showed potent iNOS inhibitory activity with value of IC50 is 0.96 μM and could interfere stability and formation of the active dimeric iNOS. It's anti-inflammatory activity in vivo was assessed by AIA rat model. Furthermore, the results of metabolic stability, CYP, PK study in vivo, acute toxicity study and subacute toxicity assessment indicated this compound had good drug-like properties for treatment.

Synthetic analogue of the natural product piperlongumine as a potent inhibitor of breast cancer cell line migration

Valli, Marilia,Altei, Wanessa,Dos Santos, Ricardo N.,De Lucca, Emilio C.,Dessoy, Marco A.,Pioli, Renan M.,Cotinguiba, Fernando,Cachet, Xavier,Michel, Sylvie,Furlan, Maysa,Dias, Luiz C.,Andricopulo, Adriano D.,Bolzani, Vanderlan S.

, p. 475 - 484 (2017)

Piperlongumine is a natural amide alkaloid isolated from several species of Piper and is described in the literature as selectively cytotoxic to several cancer cell lines. Inhibiting cell migration has gained considerable interest as an approach for discovering antimetastatic agents because this process is fundamental to metastasis. Piperlongumine, selected from cell-based assay screening of NuBBE Database, inhibited the migration of MDA-MB-231 breast cancer cells with an EC50 of 3.0 ± 1.0 μM by the Boyden chamber assay. A series of five analogous compounds based on the structure of piperlongumine were designed, synthesized and evaluated in cell migration and cytotoxicity assays. The analogue designed by molecular simplification ((E)-N-acryloyl-3-(3,4,5-trimethoxyphenyl)acrylamide) was the most active of the series, with an EC50 of 1.5 ± 1 μM. Additionally, this compound was selectively cytotoxic, with a selectivity index (SI) of 4.4.

First round of a focused library of cholera toxin inhibitors

Podlipnik, Crtomir,Velter, Ingrid,Ferla, Barbara La,Marcou, Gilles,Belvisi, Laura,Nicotra, Francesco,Bernardi, Anna

, p. 1651 - 1660 (2007)

C-Galactosides have been used as scaffolds to design a library of non-hydrolysable inhibitors of cholera toxin (CT). Test elements from the library were synthesized and found to inhibit CT binding to an asialofetuin-coated SPR chip with micromolar affinity. Preliminary results are reported.

Structure–Activity relationship of piplartine and synthetic analogues against schistosoma mansoni and cytotoxicity to mammalian cells

Campelo, Yuri,Ombredane, Alicia,Vasconcelos, Andreanne G.,Albuquerque, Lucas,Moreira, Daniel C.,Plácido, Alexandra,Rocha, Jefferson,Fokoue, Harold Hilarion,Yamaguchi, Lydia,Mafud, Ana,Mascarenhas, Yvonne P.,Delerue-Matos, Cristina,Borges, Tatiana,Joanitti, Graziella A.,Arcanjo, Daniel,Kato, Massuo J.,Kuckelhaus, Selma A. S.,Silva, Marcos P. N.,de Moraes, Josué,Leite, José Roberto S. A.

, (2018)

Schistosomiasis, caused by helminth flatworms of the genus Schistosoma, is an infectious disease mainly associated with poverty that affects millions of people worldwide. Since treatment for this disease relies only on the use of praziquantel, there is an urgent need to identify new antischistosomal drugs. Piplartine is an amide alkaloid found in several Piper species (Piperaceae) that exhibits antischistosomal properties. The aim of this study was to evaluate the structure–function relationship between piplartine and its five synthetic analogues (19A, 1G, 1M, 14B and 6B) against Schistosoma mansoni adult worms, as well as its cytotoxicity to mammalian cells using murine fibroblast (NIH-3T3) and BALB/cN macrophage (J774A.1) cell lines. In addition, density functional theory calculations and in silico analysis were used to predict physicochemical and toxicity parameters. Bioassays revealed that piplartine is active against S. mansoni at low concentrations (5–10 μM), but its analogues did not. In contrast, based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry assays, piplartine exhibited toxicity in mammalian cells at 785 μM, while its analogues 19A and 6B did not reduce cell viability at the same concentrations. This study demonstrated that piplartine analogues showed less activity against S. mansoni but presented lower toxicity than piplartine.

Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors

Angapelly, Srinivas,Ramya, P.V. Sri,Angeli, Andrea,Del Prete, Sonia,Capasso, Clemente,Arifuddin, Mohammed,Supuran, Claudiu T.

, p. 5726 - 5732 (2017)

A series of novel sulfonamides incorporating phenylacrylamido functionalities were synthesized and investigated for the inhibition of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). The physiologically and pharmacologically relevant human (h) isoforms hCA I and II (cytosolic isozymes), as well as the transmembrane tumor-associated hCA IX and XII were included in the study. These compounds showed low nanomolar or sub-nanomolar inhibition constants against hCA II (KIs in the range of 0.50–50.5 nM), hCA IX (KIs of 1.8–228.5 nM), and hCA XII (KIs of 3.5–96.2 nM) being less effective as inhibitors of the off target isoform hCA I. A detailed structure–activity relationship study demonstrates that the nature and position of substituents present on the aromatic part of the scaffold strongly influence the inhibition of CA isoforms. As hCA II, IX and XII are involved in pathologies such as glaucoma and hypoxic, and metastatic tumors, compounds of the type reported in this work may be useful preclinical candidates.

Synthetic 2′,5′-dimethoxychalcones as G2/M arrest-mediated apoptosis-inducing agents and inhibitors of nitric oxide production in rat macrophages

Wei, Bai-Luh,Teng, Chi-Huang,Wang, Jih-Pyang,Won, Shen-Jeu,Lin, Chun-Nan

, p. 660 - 668 (2007)

In an effort to develop novel antitumor or chemopreventive agents, a series of 2′,5′-dimethoxychalcone derivatives were prepared by Claisen-Schmidt condensation of appropriate acetophenones with suitable aromatic aldehyde. In vitro screening revealed low micromolar activity (IC50) against several human cancer lines. Activity in MCF-7 cells correlated with the ability to induce G2/M arrest-mediated apoptosis following drug treatment by the most potent agent, 8, an observation further reinforced by fluorescence microscopy. Compounds 3, 8, and 10 showed potent inhibitory effect on NO production in lipopolysaccharide (LPS)-activated RAW 264.7 macrophage-like cells. The present results demonstrated that 3, 8, and 10 are potential anti-inflammatory and cancer chemopreventive agents.

Synthesis and biological evaluation of novel fumagillin and ovalicin analogues

Mazitschek, Ralph,Huwe, Axel,Giannis, Athanassios

, p. 2150 - 2154 (2005)

A promising approach among the numerous efforts to cure cancer is the interruption of the tumour-induced formation of new blood vessels (angiogenesis). By suppressing angiogenesis with drugs, the tumour can neither grow to a life threatening size, nor metastasize. The natural product fumagillin 1 and the structurally related ovalicin 2 are two of the most potent anti-angiogenic compounds. Here, we report the design and synthesis of novel fumagillin and ovalicin analogues lacking reactive epoxy functionalities, which were thought to be responsible for the severe toxic side-effects observed. We also report a new synthetic approach and the determination of the anti-angiogenic properties of these compounds in endothelial cells. The Royal Society of Chemistry 2005.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 10263-19-1